- $79.66m
- $16.25m
- $7.01m
- 30
- 24
- 27
- 15
Annual balance sheet for InspireMD, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 12.6 | 34 | 17.8 | 39 | 34.6 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.945 | 1.39 | 1.25 | 2.45 | 2.25 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 15.3 | 37.1 | 21.3 | 44.2 | 40.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.71 | 1.71 | 2.47 | 2.53 | 4.73 |
| Other Long Term Assets | |||||
| Total Assets | 17.8 | 39.7 | 24.7 | 47.6 | 46.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.71 | 4.35 | 5.07 | 6.02 | 7.68 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.61 | 6.18 | 7.26 | 8.14 | 10.7 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 12.2 | 33.5 | 17.4 | 39.5 | 36.1 |
| Total Liabilities & Shareholders' Equity | 17.8 | 39.7 | 24.7 | 47.6 | 46.8 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |